Physical Activity Intervention for the Improvement of Pain in Young, Hispanic Breast Cancer Survivors
NCT ID: NCT06260332
Last Updated: 2025-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
25 participants
INTERVENTIONAL
2023-10-20
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Program for Early Breast Cancer Survivors
NCT01140282
Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)
NCT05011279
Moderate-Intensity Exercise and Pain Sensitization in Breast Cancer Survivors: A Case-Based Study
NCT07128030
Yoga Study in Breast Cancer Patients
NCT00476203
Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors
NCT02848989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To assess the feasibility of a physical activity intervention in young, Hispanic women with chronic post-operative pain after breast surgery for invasive breast cancer, termed post breast surgery pain syndrome (PBSPS) for this study.
SECONDARY OBJECTIVES:
I. To assess the preliminary efficacy of a physical activity intervention in decreasing pain in young, Hispanic women with PBSPS.
II. To assess the preliminary efficacy of the physical activity intervention in increasing physical activity and improving health-related quality of life (hrQOL).
OUTLINE:
Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supportive Care (Fitbit)
Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11.
Supportive Care (Fitbit)
Wear Fitbit, Use Fitbit application, Receive educational materials, attend coaching calls, Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supportive Care (Fitbit)
Wear Fitbit, Use Fitbit application, Receive educational materials, attend coaching calls, Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any breast surgery (lumpectomy or mastectomy)
* Baseline low to moderate activity level (exercise less than 120 minutes a week)
* PBSPS defined as pain in the area of breast surgery of at least moderate intensity (\>= 4 on a scale of 1-10), located in the ipsilateral beast/chest wall, axilla or arm, lasting at least 6 months, and occurring at least 50% of the time
* Self-identified as Hispanic/Latinx
* Age, \>= 18 and =\< 60 years
* Endocrine therapy and ovarian suppression is allowed
Exclusion Criteria
* Meeting or exceeding physical activity guidelines (\> 150 minutes per week of moderate-intensity exercise)
* Unable to speak, read, and understand English or Spanish
* Severe impairments (in seeing or hearing) or pre-existing medical limitations for engaging in daily physical activity. This is defined as the ability to walk 3 blocks without stopping to rest and without using an assistive device
* Unwilling to use a study provided smartphone (if do not already own one) and wear activity trackers/monitors
* Adults not able to consent are excluded from participation
* Based on the age criteria (18 years and older), individuals who are not yet adults (infants, children, teenagers) may not participate in this study due to the same age criteria above
* Pregnant women
* Prisoners may not participate in this study as this is a study of free-living individuals
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of New Mexico
OTHER
New Mexico Cancer Research Alliance
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacklyn M Nemunaitis, MD
Role: PRINCIPAL_INVESTIGATOR
New Mexico Cancer Research Alliance
Cindy K Blair, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
New Mexico Cancer Research Alliance
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
NIH. (n.d.). Cancer of the breast (female) - cancer stat facts. SEER. Retrieved January 22, 2023
PROMIS: Patient-Reported Outcomes Measurement Information System
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-293
Identifier Type: OTHER
Identifier Source: secondary_id
INST UNM 2302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.